{"type":"rich","version":"1.0","provider_name":"Transistor","provider_url":"https://transistor.fm","author_name":"Middle East Regulatory Policy Brief","title":"[Middle East] Key Regulatory Updates on Drug Safety & Patient Alerts","html":"<iframe width=\"100%\" height=\"180\" frameborder=\"no\" scrolling=\"no\" seamless src=\"https://share.transistor.fm/e/84b93a1f\"></iframe>","width":"100%","height":180,"duration":226,"description":"Covering Patient Safety, Drug Safety, Pharmacovigilance, Osteonecrosis of the Jaw, Pharmaceutical. This episode covers critical regulatory developments in patient safety, pharmacovigilance, and pharmaceutical oversight, including updated educational materials for Atrasentan, Denosumab, and Adalimumab, plus voluntary recalls impacting multiple drug batches.","thumbnail_url":"https://img.transistorcdn.com/G78bdEqj2J-KFXn5VpwOAHWW5C0One0rBiZjO8Wh73U/rs:fill:0:0:1/w:400/h:400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS8zYzVi/NWFhMDlkOGVkNDAx/YjY5YmQ0ZDIzNThl/YTc5OC5wbmc.webp","thumbnail_width":300,"thumbnail_height":300}